Zhuang, Y.; Wang, J.; Li, H.; Chen, Y.; Chen, C.; Wang, D.W.
Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis. Biomedicines 2022, 10, 2941.
https://doi.org/10.3390/biomedicines10112941
AMA Style
Zhuang Y, Wang J, Li H, Chen Y, Chen C, Wang DW.
Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis. Biomedicines. 2022; 10(11):2941.
https://doi.org/10.3390/biomedicines10112941
Chicago/Turabian Style
Zhuang, Yan, Jin Wang, Huihui Li, Yanghui Chen, Chen Chen, and Dao Wen Wang.
2022. "Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis" Biomedicines 10, no. 11: 2941.
https://doi.org/10.3390/biomedicines10112941
APA Style
Zhuang, Y., Wang, J., Li, H., Chen, Y., Chen, C., & Wang, D. W.
(2022). Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis. Biomedicines, 10(11), 2941.
https://doi.org/10.3390/biomedicines10112941